Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-21-OCRP-IIRA: CDMRP Ovarian Cancer Investigator-Initiated Research Award

Closed Closed July 8, 2021 Opportunity W81XWH-21-OCRP-IIRA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2021.

• Total funding$11.8 million
• Expected awards11
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s). Clinical trials are not supported with this award mechanism. New for FY21 is the Partnering PI Option: As a method to facilitate progress in addressing critical problems or questions through collaborative efforts, the FY21 OCRP is offering a Partnering PI Option for this award mechanism. The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, work synergistically on a single project. If recommended for funding, each PI will be named to an individual award within the recipient organization.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.